Cardiol Therapeutics Statistics Share Statistics Cardiol Therapeutics has 83.73M
shares outstanding. The number of shares has increased by 2.61%
in one year.
Shares Outstanding 83.73M Shares Change (YoY) 2.61% Shares Change (QoQ) 1.31% Owned by Institutions (%) 7.67% Shares Floating 80.58M Failed to Deliver (FTD) Shares 196 FTD / Avg. Volume 0.02%
Short Selling Information The latest short interest is 2.19M, so 2.62% of the outstanding
shares have been sold short.
Short Interest 2.19M Short % of Shares Out 2.62% Short % of Float 2.72% Short Ratio (days to cover) 2.71
Valuation Ratios The PE ratio is -3.59 and the forward
PE ratio is -2.76.
Cardiol Therapeutics's PEG ratio is
-0.23.
PE Ratio -3.59 Forward PE -2.76 PS Ratio 0 Forward PS 86.1 PB Ratio 5.33 P/FCF Ratio -5.25 PEG Ratio -0.23
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Cardiol Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.52,
with a Debt / Equity ratio of 0.01.
Current Ratio 4.52 Quick Ratio 4.52 Debt / Equity 0.01 Debt / EBITDA n/a Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.04M Employee Count 18 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -45.69% in the
last 52 weeks. The beta is 0.62, so Cardiol Therapeutics's
price volatility has been higher than the market average.
Beta 0.62 52-Week Price Change -45.69% 50-Day Moving Average 1.16 200-Day Moving Average 1.21 Relative Strength Index (RSI) 44.93 Average Volume (20 Days) 869,560
Income Statement
Revenue n/a Gross Profit n/a Operating Income -40.28M Net Income -36.68M EBITDA -40.11M EBIT -40.28M Earnings Per Share (EPS) -0.51
Full Income Statement Balance Sheet The company has 30.58M in cash and 158.53K in
debt, giving a net cash position of 30.42M.
Cash & Cash Equivalents 30.58M Total Debt 158.53K Net Cash 30.42M Retained Earnings -179.25M Total Assets 19.94M Working Capital 11.75M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -25.06M
and capital expenditures -21.29K, giving a free cash flow of -25.08M.
Operating Cash Flow -25.06M Capital Expenditures -21.29K Free Cash Flow -25.08M FCF Per Share -0.35
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
